Gsk-256066
6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide
Molecular Identity
Gsk-256066
6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide
PubChem CID: 9827968
GSK-256066 is gsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others.
2D Structure
Properties
C27H26N4O5S
Molecular Formula
518.60
Molecular Weight
g/mol
518.1624
Exact Mass
Da
3.8
XLogP
Drug-like (Lipinski: < 5)
140
TPSA
May have limited oral absorption
2
H-Bond Donors
7
H-Bond Acceptors
922
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)CIsomeric SMILES
SMILES: CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)CSynonyms(20)
GSK256066801312-28-7GSK-256066GSK 256066UNII-2D6GK059SR2D6GK059SRDTXSID302300903-Quinolinecarboxamide, 6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-4-((3-methoxyphenyl)amino)-8-methyl-6-[3-(dimethylcarbamoyl)benzenesulfonyl]-4-[(3-methoxyphenyl)amino]-8-methylquinoline-3-carboxamideD-Phenylalanine, N-((phenylmethoxy)carbonyl)-L-phenylalanyl-, methyl ester6-(3-(dimethylcarbamoyl)benzenesulfonyl)-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamideRefChem:144515DTXCID301525816-[[3-[(DIMETHYLAMINO)CARBONYL]PHENYL]SULFONYL]-4-[(3-METHOXYPHENYL)AMINO]-8-METHYL-3-QUINOLINECARBOXAMIDE6-(3-(dimethylcarbamoyl)phenylsulfonyl)-4-(3-methoxyphenylamino)-8-methylquinoline-3-carboxamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Gsk-256066
Loading drug network...